Subscribe Alumni Newsroom Offices Contact Us About Us Careers

Sectors

Energy & Infrastructure

Innovation in Energy & Infrastructure

Aerial view of a city at night with illuminated grid-like streets and buildings under a cloudy sky, lines and dots digitally added to emphasize the city grid layout, reflecting the structured precision found in top law offices.

Airport & Aviation

Aviation & Aircraft Transactions

Food & Beverage

Regulatory Compliance, Food Safety

Infringement Litigation, Leasing

Health Care & Life Sciences

Advances in Health Care & Life Sciences

Banking & Finance, Cannabis Litigation

Hospitality & Leisure

Hotels & Resorts, Golf Clubs

Sports & Entertainment

Sports Facility Development, Media Deals

Innovative Technology

Leveraging AI, Cloud Computing, Genomics

Generational Wealth, Wealth Management

Offshore Oil & Gas, Admiralty Law

Manufacturing

End-to-End Business Solutions

Fashion, Apparel & Beauty

Trademark, Manufacturing, Supply Chain

Racial Justice & Equity

Public Affairs, Small Business Services

All Practice Areas

Corporate

Corporate Overview

Capital Markets & Public Company Advisory Equity, Debt, Governance, Transactions

Employee Benefits & Executive Compensation Health Plans, 401 (k), and Pension Plans

Environmental Permitting, Environmental Litigation

Environmental, Social, and Governance (ESG) Impact Investing, Energy Transition

Estate Planning Family Offices, Wealth Management, Trust

Finance Financial Institutions, Public Private Partnerships

Fund Formation & Investment Management GPs, LPs, Middle Market Investment

Government Solutions Lobbying, Policy, State Attorneys General

Health Care Health Care Regulatory and Transactions

Insurance Reinsurance, Insurance Transactions

Private Equity Middle Market PE, Investment Lifecycle

Real Estate Real Estate Law, Commercial Development

Securities, Commodities & Exchange Regulation Securities Law, Commodities

Taxation State and Local Tax, Opportunity Zones

Transactions Mergers and Acquisitions

Venture & Growth Capital Angel Funds, Venture Funds

Intellectual Property

Intellectual Property Overview

Chemical, Biotechnology & Pharmaceutical Full Cycle Patent Strategy and Services

Electronics Full Cycle Patent Strategy and Services

IP Asset Management IP Portfolio Strategy and Management

IP Due Diligence IP Audit, Investment, and Monetization

IP Litigation IP Asset Enforcement and Defense

ITC Section 337 Proceedings IP Import Infringement Investigations

Mechanical & Electromechanical Technologies Full Cycle Patent Strategy and Services

PTAB Trials Post-Grant Proceedings

Technology Transactions, Cybersecurity, and Privacy IT Contracting and Data Governance

Trademark, Copyright & Advertising Counseling Trademark Protection, Copyright Defense

Litigation

Litigation Overview

Antitrust & Competition Antitrust Litigation, Antitrust Regulation

Appellate Appellate Attorneys

Bankruptcy & Business Reorganizations Asset Acquisition, Restructuring

Commercial Litigation Bet the Company Litigation, eDiscovery

Construction Construction Litigation, Arbitrations

Consumer Law, Finance & Class Action Group Consumer Class Action Defense

Distribution & Franchise Antitrust and Competition, Trademarks

Energy Litigation Oil & Gas Litigation, Dispute Resolution

Government Enforcement Defense & Investigations False Claims Act, International Trade

Health Care Litigation Dispute Resolution, Civil Lawsuits

Hospitality Litigation TCPA Compliance, Franchise Disputes

Insurance & Reinsurance Litigation Casualty Insurance, Insurance Fraud

International Arbitration Cross-Border Dispute Resolution

Labor & Employment Union/Employer Matters, Harassment Claims

Privacy, Security & Information Management Privacy Litigation, Privacy Compliance

Product Liability Life Sciences Product Liability

Securities Enforcement & Litigation SEC Enforcement, Auditor Defense

Tax Controversy Tax Dispute, Tax Audit, Tax Litigation

Trade Secret Noncompete Litigation Unfair Competition, Noncompete Agreement

Trial Team Federal & State Courts, Jury Trials

English

Popular Searches

IP Litigation
Trump Administration Resources
Patent
Energy & Infrastructure
Artificial Intelligence

Foley & Lardner Advises RXBAR in $600 Million Sale to Kellogg Company

October 27, 2017

Share on LinkedIn

Share on Twitter

Foley represented RXBAR in its acquisition by Kellogg Company in a $600 million deal.

Chicago Bar Company d/b/a RXBAR, maker of the popular protein bar RXBAR, will continue to operate as an independent business headquartered in Chicago.

Foley & Lardner has represented RXBAR since 2013 and served as its outside general counsel in addition to advising on the sale. “RXBAR is a great example of how Foley works with growth companies and helps them as their business scales,” said partner Chris Cain, who led the Foley M&A team along with Chris Rasmussen.

People

Christopher J. Rasmussen
Christopher C. Cain

Sectors

Food & Beverage

Practice Areas

Mergers & Acquisitions
Transactions

People

A man with a gray beard and glasses, dressed in a dark suit and white shirt, stands in a blurred indoor setting—typical of seasoned Chicago lawyers experienced in litigation support.

Christopher J. Rasmussen

[email protected]

Chicago 312.832.4384

Smiling man with dark hair wearing a light gray plaid suit jacket and white shirt, standing in a modern, blurred corporate law office—a professional among Chicago lawyers.

Christopher C. Cain

[email protected]

Madison 608.258.4241

Related News

September 18, 2026 In the News

Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations

Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”

September 17, 2026 In the News

Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®

Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.

September 15, 2026 In the News

David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials

Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.

We look beyond the law to focus on the constantly evolving demands facing our clients.

Cookie Preferences

© 2026 Foley & Lardner LLP

Attorney Advertisement

Images of people may not be Foley personnel.

Connect on LinkedIn

Connect on Instagram

Connect on Facebook

Connect on Twitter

Connect on Youtube